Ketamine vs Esketamine for Acute Suicidal Ideation — NMA (T1/T2/T3)

Reproducible submission package for the network meta-analysis (NMA) comparing IV ketamine vs intranasal esketamine on acute anti-suicidal outcomes (T1 2–24 h; T2 48–72 h; T3 ~7 d). Includes: • Extraction CSVs, analysis scripts, and rendered figures/tables • PRISMA 2020 materials, RoB 2, and GRADE Data license: CC BY 4.0; Code license: MIT (see LICENSE inside ZIP).